# A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

> **NCT06380816** · PHASE1,PHASE2 · RECRUITING · sponsor: **Cancer Research UK** · enrollment: 167 (estimated)

## Conditions studied

- Advanced Solid Tumours
- Squamous Cell Carcinoma of Head and Neck
- Carcinoma, Non-Small-Cell Lung
- Colorectal Neoplasms
- Triple Negative Breast Neoplasms
- Carcinoma, Renal Cell (Clear Cell Only)
- Esophageal Neoplasms
- Stomach Neoplasms (Excluding Gastrointestinal Stromal Tumors)
- Uterine Cervical Neoplasms
- Ovarian Neoplasms
- Pancreatic Neoplasms

## Interventions

- **DRUG:** UCB4594

## Key facts

- **NCT ID:** NCT06380816
- **Lead sponsor:** Cancer Research UK
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-09
- **Primary completion:** 2029-11
- **Final completion:** 2029-11
- **Target enrollment:** 167 (ESTIMATED)
- **Last updated:** 2026-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06380816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06380816, "A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT06380816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*